Distribution of GynTect® may reduce uncertainty about cervical cancer in the family planning phase
Survey by clinicians and Oncgnostics quantifies significant psychological distress by repetitive diagnostic cycles in cervical cancer follow-up testing. JENA, GERMANY, December 12, 2019 /EINPresswire.com/ -- Oncgnostics GmbH, a Jena/Germany based …